NYSEAMERICAN:INFU InfuSystem (INFU) Stock Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free INFU Stock Alerts $8.12 +0.51 (+6.70%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$7.65▼$8.1250-Day Range N/A52-Week Range$7.57▼$11.44Volume27,714 shsAverage Volume44,007 shsMarket Capitalization$172.63 millionP/E Ratio270.76Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityStock AnalysisChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainability Get InfuSystem alerts: Email Address InfuSystem MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.15% of Float Sold ShortDividend StrengthN/ASustainability-1.20Upright™ Environmental ScoreNews Sentiment0.50Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.96 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for InfuSystem. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.15% of the float of InfuSystem has been sold short.Short Interest Ratio / Days to CoverInfuSystem has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in InfuSystem has recently decreased by 7.83%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. Previous Next 4.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInfuSystem has received a 55.56% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Medical dispensing pumps", and "Catheters" products. See details.Environmental SustainabilityThe Environmental Impact score for InfuSystem is -1.20. Previous Next 3.6 News and Social Media Coverage News SentimentInfuSystem has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.32 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for InfuSystem this week, compared to 1 article on an average week.Search Interest1 people have searched for INFU on MarketBeat in the last 30 days. MarketBeat Follows1 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have not sold or bought any company stock.Percentage Held by Insiders18.50% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 270.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 141.29.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 270.76, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 235.73.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 3.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy About InfuSystem Stock (NYSEAMERICAN:INFU)InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.Read More INFU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INFU Stock News HeadlinesApril 25, 2024 | americanbankingnews.comInfuSystem (NYSEAMERICAN:INFU) Stock Price Passes Above Two Hundred Day Moving Average of $0.00April 17, 2024 | americanbankingnews.comInfuSystem (NYSEAMERICAN:INFU) Raised to "Strong-Buy" at StockNews.comApril 27, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.April 3, 2024 | businesswire.comInfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-KApril 1, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Forian (FORA), Achieve Life Sciences (ACHV) and P3 Health Partners (PIII)March 26, 2024 | investorplace.comDouble Down: 7 Beaten-Down Growth Stocks to Buy Hand Over FistMarch 20, 2024 | money.usnews.comInfuSystem Holdings IncMarch 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: InfuSystem Holdings, Inc. (INFU), Aquestive Therapeutics (AQST)April 27, 2024 | Paradigm Press (Ad)Biden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.March 15, 2024 | finance.yahoo.comInfuSystem Holdings, Inc. (AMEX:INFU) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comQ4 2023 InfuSystem Holdings Inc Earnings CallMarch 14, 2024 | msn.comInfuSystem GAAP EPS of $0.00 in-line, revenue of $31.77M beats by $1.77MMarch 14, 2024 | finance.yahoo.comInfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023March 14, 2024 | finance.yahoo.comInfuSystems Holdings Inc (INFU) Reports Solid Growth in 2023 with Record Net Revenues and ...March 8, 2024 | businesswire.comInfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024February 29, 2024 | seekingalpha.comInfuSystem Holdings: 2024 Will Be A Year Of MonetizationFebruary 1, 2024 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: EDAP TMS (EDAP), DermTech (DMTK)January 10, 2024 | markets.businessinsider.comAnalysts’ Top Consumer Cyclical Picks: Carbon Revolution (CREV), Kura Sushi USA (KRUS)January 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), Dynavax (DVAX)January 2, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Streamline Health Solutions (STRM), MiMedx Group (MDXG) and Integra Lifesciences (IART)November 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), BioLife Solutions (BLFS) and Xeris Pharmaceuticals (XERS)November 7, 2023 | msn.comInfuSystem GAAP EPS of $0.03, revenue of $31.9MNovember 6, 2023 | markets.businessinsider.comAnalysts’ Top Healthcare Picks: ModivCare (MODV), Clearside Biomedical (CLSD)November 6, 2023 | msn.comInfuSystem Q3 2023 Earnings PreviewNovember 3, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM), BioMarin Pharmaceutical (BMRN) and Atricure (ATRC)October 31, 2023 | finance.yahoo.comInfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023October 27, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: CVRx (CVRX) and Merit Medical Systems (MMSI)See More Headlines Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today4/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSEAMERICAN:INFU Previous SymbolNYSE:INFU CUSIPN/A CIK1337013 Webir.infusystem.com Phone(124) 291-1210Fax800-455-4338Employees499Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E Ratio270.76 Forward P/E RatioN/A P/E GrowthN/ANet Income$870,000.00 Net Margins0.69% Pretax Margin1.47% Return on Equity1.73% Return on Assets0.85% Debt Debt-to-Equity Ratio0.56 Current Ratio1.95 Quick Ratio1.54 Sales & Book Value Annual Sales$125.79 million Price / Sales1.37 Cash Flow$0.66 per share Price / Cash Flow12.35 Book Value$2.47 per share Price / Book3.29Miscellaneous Outstanding Shares21,260,000Free Float17,331,000Market Cap$172.63 million OptionableNot Optionable Beta1.24 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Richard A. DiIorio (Age 49)CEO & Director Comp: $1.14MMs. Carrie A. Lachance B.S.N. (Age 47)M.B.A., R.N., President, COO & Director Comp: $831.31kMr. Barry G. Steele (Age 53)Executive VP & CFO Comp: $725.43kMr. Addam Chupa (Age 45)Executive VP & Chief Information Officer Mr. Jerod Funke (Age 49)Executive VP & Chief HR Officer Jeanie LatzCorporate SecretaryMore ExecutivesKey CompetitorsAlpha Tau MedicalNASDAQ:DRTSQuipt Home MedicalNASDAQ:QIPTOrchestra BioMedNASDAQ:OBIOProfound MedicalNASDAQ:PROFClearPoint NeuroNASDAQ:CLPTView All CompetitorsInsiders & InstitutionsGreenwood Capital Associates LLCSold 3,018 shares on 3/5/2024Ownership: 0.449%Wasatch Advisors LPBought 27,881 shares on 2/14/2024Ownership: 3.997%Ranger Investment Management L.P.Bought 30,835 shares on 2/14/2024Ownership: 3.257%Teton Advisors Inc.Sold 5,000 shares on 2/13/2024Ownership: 0.921%Cove Street Capital LLCSold 49,137 shares on 2/12/2024Ownership: 1.933%View All Insider TransactionsView All Institutional Transactions INFU Stock Analysis - Frequently Asked Questions Are investors shorting InfuSystem? InfuSystem saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 215,400 shares, a decline of 7.8% from the March 31st total of 233,700 shares. Based on an average trading volume of 44,500 shares, the short-interest ratio is currently 4.8 days. Approximately 1.2% of the shares of the company are sold short. View InfuSystem's Short Interest. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) posted its quarterly earnings results on Monday, November, 15th. The medical instruments supplier reported ($0.02) earnings per share for the quarter, missing the consensus estimate of $0.03 by $0.05. The medical instruments supplier earned $26.57 million during the quarter, compared to analyst estimates of $28 million. InfuSystem had a net margin of 0.69% and a trailing twelve-month return on equity of 1.73%. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some companies that other InfuSystem investors own include Macquarie Infrastructure (MIC), Second Sight Medical Products (EYES), Otelco (OTEL), Pershing Gold (PGLC), Palatin Technologies (PTN), AgroFresh Solutions (AGFS), Advanced Micro Devices (AMD) and Digital Turbine (APPS). How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEAMERICAN:INFU) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
